These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26316708)

  • 1. Paget's disease of bone: an osteoimmunological disorder?
    Numan MS; Amiable N; Brown JP; Michou L
    Drug Des Devel Ther; 2015; 9():4695-707. PubMed ID: 26316708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
    Neale SD; Schulze E; Smith R; Athanasou NA
    QJM; 2002 Apr; 95(4):233-40. PubMed ID: 11937650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
    Salmon P
    J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
    Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.
    Rabjohns EM; Hurst K; Ghosh A; Cuellar MC; Rampersad RR; Tarrant TK
    Curr Allergy Asthma Rep; 2021 Mar; 21(4):23. PubMed ID: 33768371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
    Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
    J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in Paget's disease and their relevance to oncology.
    Roodman GD
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):15-21. PubMed ID: 11544571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
    Polyzos SA; Anastasilakis AD; Efstathiadou Z; Kita M; Litsas I; Avramidis A; Arsos G; Moralidis E; Gerou S; Pavlidou V; Papatheodorou A; Terpos E
    Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of Paget's disease and osteoclast abnormalities.
    Reddy SV
    J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
    Hoyland JA; Freemont AJ; Sharpe PT
    J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.
    Criscitiello C; Viale G; Gelao L; Esposito A; De Laurentiis M; De Placido S; Santangelo M; Goldhirsch A; Curigliano G
    Cancer Treat Rev; 2015 Feb; 41(2):61-8. PubMed ID: 25499997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANKing the importance of measles virus in Paget's disease.
    Ross FP
    J Clin Invest; 2000 Mar; 105(5):555-8. PubMed ID: 10712423
    [No Abstract]   [Full Text] [Related]  

  • 19. Paget's disease of bone-genetic and environmental factors.
    Singer FR
    Nat Rev Endocrinol; 2015 Nov; 11(11):662-71. PubMed ID: 26284446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Report of Bone Paget's Disease with Concurrent Psoriasis and Positive Celiac Serology.
    Sabooniha F
    Curr Med Imaging; 2023 Mar; ():. PubMed ID: 37018522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.